Table 1 Kinetic Parameters Determined for AaCHYMO Using Commercially Available Chymotrypsin- and AaCHYMO-Specifically Designed AMC Fluorescent Substrates Compared to Human and Bovine Chymotrypsin.

From: Biochemical and physiological characterization of Aedes aegypti midgut chymotrypsin

Substrate

AaCHYMO

Human Chymotrypsin

Bovine Chymotrypsin

Human/AaCHYMO

Bovine/AaCHYMO

kcat (s-1)

Km (µM)*

kcat/Km (M-1 s-1)

Specific Activity

kcat (s-1)

Km (µM)*

kcat/Km (M-1 s-1)

Specific Activity

kcat (s-1)

Km (µM)*

kcat/Km (M-1 s-1)

Specific Activity

kcat/Km

kcat/Km

µmol min-1(mg protein)-1

µmol min-1(mg protein)-1

µmol min-1(mg protein)-1

ratio

ratio

Commercially Available

Suc-Ala-Ala-Pro-Phe-AMC

4.81

9.72

4949578

11.0

608.7

114.2

5329831

1460.8

832

18.77

44326052

1997

1.08

9.0

Suc-Ala-Ala-Phe-AMC

0.92

83.16

11087

2.10

8.38

30.0

279724

20.1

100.3

48.44

2069915

240.6

25.2

186.7

MeO-Suc-Arg-Pro-Tyr-AMC

14.1

9.52

1481520

32.1

1597

12.3

129915921

3832

3146

8.014

392563015

7550

87.7

265.0

Suc-Leu-Leu-Val-Tyr-AMC

0.06

6.72

9410

0.14

597

6.6

89814954

1432.8

580.3

10.67

54389253

1393

9545

5780

Suc-Arg-Pro-Phe-His-Leu-Leu-Val-Tyr-MCA

0.61

1.54

394925

1.38

37.4

1.2

31562676

89.8

6.82

0.57

11959064

16.4

79.9

30.3

Suc-Leu-Tyr-AMC

0.07

7.57

8712

0.15

5.16

10.6

485732

12.4

8.58

16.29

526499

20.6

55.8

60.4

Suc-Ile-Ile-Trp-MCA

5.14

61.68

83279

11.7

794

12.2

65188834

1905.6

7893

13.37

590376465

18944

782.8

7089

Ac-Ala-Asn-Trp-AMC

2.69

33.31

80636

6.12

425

25.1

16932271

1020

255.9

56.16

4556624

614.2

210.0

56.5

Z-Leu-Leu-Leu-MCA

0.03

0.13

204048

0.062

-

-

-

-

-

-

-

-

-

-

Ac-Pro-Ala-Leu-AMC

0.02

9.00

1818

0.037

-

-

-

-

0.0061

7.63

801

0.014664

-

0.44

Z-Gly-Gly-Leu-AMC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Z-Val-Lys-Met-MCA

0.07

1.21

60149

0.166

0.41

6.4

64896

0.991

6.32

6.06

1043215

15.2

1.08

17.3

Boc-Val-Leu-Lys-AMC

-

-

-

-

5.17

225.5

22942

12.4

-

-

-

-

-

-

Z-Arg-Arg-AMC

-

-

-

-

4.79

568.2

8424

11.5

-

-

-

-

-

-

AaCHYMO-Specifically Designed

Ac-Ala-His-Val-Phe-AMC

26.9

8.11

33173056

61.3

83.8

30.0

2797242

201.2

339.7

31.0

10974690

815.2

0.084

0.331

Ac-Ala-His-Leu-Phe-AMC

10.6

4.40

2419697

24.3

23.4

13.7

1706754

56.2

40.1

14.1

2849692

96.2

0.705

1.18

Ac-Ala-His-Val-Tyr-AMC

0.817

7.04

116115

1.86

8.4

25.9

325097

20.2

8.58

23.9

359737

20.6

2.80

3.10

Ac-Ala-His-Leu-Tyr-AMC

6.07

1.24

4888531

13.8

248.3

12.7

19548556

595.8

642.7

19.8

32408808

1542.4

4.00

6.63

Ac-Ala-His-Thr-Trp-AMC

0.072

7.30

9815

0.163

190.0

25.1

7583500

455.9

339.7

19.9

17094447

815.2

772.6

1741.7

Ac-Ala-His-Asp-Trp-AMC+

-

-

-

-

48.5

14.8

3285908

116.4

272.7

20.2

13525132

654.4

-

-

Ac-Ala-His-Val-Trp-AMC

5.51

6.32

872249

12.6

438.7

18.9

23222163

1052.8

1839.7

15.3

120318291

4415.2

26.6

137.9

Ac-Ala-His-Val-Leu-AMC

5.42

3.95

1372350

12.3

1.26

33.1

38176

3.03

2.30

31.9

72076

5.51

0.028

0.053

Ac-Pro-His-Val-Met-AMC

133.1

10.7

12482802

303.4

2.9

18.3

157534

6.90

4.19

11.3

371420

10.1

0.013

0.030

Ac-Ala-His-Val-Met-AMC

2.83

4.30

658452

6.46

8.61

43.8

196589

20.7

8.93

29.7

300460

21.4

0.299

0.456

  1. *Km and vmax determined with the Michaelis-Menten non-linear regression analysis tool at a 95% Confidence Interval (CI) using GraphPad Prism.
  2. - Neglibile activity detected under any of the conditions tested, exceeded lower level of detection for AMC >1 nM.
  3. + Non-preferred amino acid at the P2 site.